scanX
Dr Reddys Laboratories

Dr Reddys Laboratories

1,246.10
+11.60
(0.94%)
hide
Key Fundamentals
Add Ratio
Market Cap
1,03,033.10 Cr
EPS
67.89
PE Ratio
18.13
Dividend Yield
0.65 %
Industry
Healthcare
52 Week High
1,405.90
52 Week Low
1,020.00
PB Ratio
3.07
Debt to Equity
0.11
Sector
Pharmaceuticals
Analyst Rating and Forecast
- By Refinitiv from38 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+34.21 %
+34.21 %
Hold
Hold+31.58 %
+31.58 %
Sell
Sell+34.21 %
+34.21 %
Forecast For
Actual

Company News

View All News
Caret
positive
Dr Reddy's and Hetero to Launch Generic HIV Prevention Drug at $40 Annually by 2027Sep 24, 2025
Dr Reddy's Laboratories and Hetero Labs announced they will sell generic versions of lenacapavir, an HIV prevention drug, for approximately $40 per year starting in 2027. The original drug, developed by Gilead Sciences and branded as Yeztugo, is a twice-yearly injection that showed nearly 100% effectiveness in preventing HIV during large trials, but costs around $28,000 annually in the US. Both companies received royalty-free licenses from Gilead to produce and sell the drug in 120 low- and lower-middle-income countries. Unitaid, Clinton Health Access Initiative, and Wits RHI are supporting Dr Reddy's efforts, while the Gates Foundation is working with Hetero. The generic pricing aims to match oral PrEP costs and could benefit millions in low-income countries. Experts estimate long-term demand could reach 10 million people or more, making affordable generics crucial for broader access.
positive
Dr. Reddy's Receives Positive CHMP Opinion for Denosumab Biosimilar AVT03Sep 22, 2025
Dr. Reddy's received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for AVT03, a denosumab biosimilar. AVT03 is planned as a biosimilar to Prolia and XGEVA. The positive CHMP opinion represents a regulatory milestone in the European approval process for the biosimilar product.
neutral
Dr. Reddy's Laboratories Schedules Q2 Results Review for October 24Sep 22, 2025
Dr. Reddy's Laboratories has announced it will review its Q2 results on October 24. The pharmaceutical company has set this date for examining its quarterly financial performance.
View more

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Sun Pharmaceutical
1,658.50
#1 3,91,475.50
34.13
#1 54,729.00
9.71
#1 10,980
-19.84
58.34
Divis Laboratories
6,132.00
1,62,480.00
70.48
9,712.00
18.67
2,191
26.74
56.91
Torrent Pharmaceuticals
3,550.50
1,20,791.20
59.78
11,539.40
6.99
1,911
19.91
46.90
Cipla
1,513.10
1,20,726.90
22.39
28,409.50
7.12
5,291
9.88
44.95
Dr Reddys Laboratories
1,246.10
#5 1,03,033.10
#1 18.13
#2 33,741.20
#4 16.73
#2 5,725
#8 1.26
43.68
Mankind Pharma
2,479.40
1,01,328.10
53.49
12,744.20
#1 20.90
2,007
-18.14
44.46
Zydus Life Science
994.45
99,209.60
21.29
23,511.00
18.55
4,615
2.60
46.28
Lupin
1,957.60
87,039.10
23.53
22,909.50
13.74
3,306
#1 51.64
49.43
Alkem Laboratories
5,480.50
65,683.00
28.88
13,458.30
3.70
2,216
21.39
56.59
Abbott
29,690.00
63,588.50
43.69
6,684.70
9.64
1,414
11.55
36.03
Growth Rate
Revenue Growth
16.73 %
Net Income Growth
2.64 %
Cash Flow Change
2.19 %
ROE
-14.54 %
ROCE
-13.11 %
EBITDA Margin (Avg.)
-6.42 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
3,887
3,813
4,061
4,030
3,841
3,302
3,630
3,747
3,575
3,354
3,578
3,849
3,580
3,779
3,937
3,961
4,116
4,290
4,867
4,469
4,516
4,512
4,955
5,015
4,829
5,044
5,993
5,394
5,569
6,079
6,361
6,835
6,443
6,917
7,199
7,434
7,284
7,866
8,330
8,513
9,034
8,836
Expenses
3,271
2,765
2,888
2,996
3,313
2,855
2,989
2,859
3,021
3,010
2,890
3,041
2,990
2,968
3,058
3,060
3,211
3,117
3,749
4,686
3,500
3,305
3,755
4,403
3,715
4,211
4,427
4,123
5,024
4,292
4,433
4,851
4,781
4,696
4,894
5,214
5,283
5,566
5,962
6,108
6,531
6,399
EBITDA
616
1,048
1,173
1,034
528
447
640
888
553
344
687
808
590
812
879
901
905
1,174
1,118
-217
1,016
1,207
1,200
613
1,114
833
1,566
1,271
545
1,787
1,928
1,983
1,662
2,221
2,305
2,220
2,001
2,300
2,368
2,405
2,503
2,437
Operating Profit %
15 %
26 %
28 %
25 %
12 %
12 %
17 %
23 %
15 %
9 %
18 %
20 %
15 %
20 %
19 %
21 %
20 %
19 %
22 %
-7 %
21 %
25 %
23 %
11 %
21 %
14 %
23 %
23 %
8 %
18 %
30 %
28 %
24 %
30 %
29 %
28 %
25 %
27 %
26 %
27 %
23 %
25 %
Depreciation
0
203
224
235
277
244
262
267
254
259
270
272
276
279
279
290
287
289
313
287
274
292
317
311
309
284
294
294
293
302
309
324
316
353
376
374
368
381
397
471
455
476
Interest
23
28
22
16
17
15
13
16
20
22
22
17
18
20
21
24
25
30
30
15
23
23
25
19
30
19
23
22
32
35
31
42
35
37
35
39
59
60
76
82
66
83
Profit Before Tax
593
831
960
733
273
199
396
622
337
81
409
547
314
529
599
601
606
869
786
-506
736
901
873
295
815
556
1,273
974
259
1,468
1,614
1,638
1,329
1,850
1,917
1,829
1,605
1,883
1,917
1,874
2,005
1,905
Tax
74
184
185
147
150
45
87
130
-1
14
103
244
42
53
81
101
151
193
-321
33
-45
306
101
267
258
175
277
265
162
279
499
394
369
445
435
448
295
490
576
470
419
495
Net Profit
519
647
775
586
123
154
309
492
338
67
305
303
272
476
518
500
455
677
1,107
-538
781
595
772
28
557
380
996
709
97
1,189
1,114
1,244
960
1,405
1,482
1,381
1,310
1,392
1,342
1,404
1,587
1,410
EPS in ₹
30.45
37.99
45.42
34.34
7.19
9.06
18.64
29.72
20.38
4.02
18.42
18.25
16.39
28.69
31.22
30.16
27.45
40.81
66.78
-32.48
47.12
35.87
46.54
1.68
33.61
22.95
60.03
42.75
5.84
71.64
67.13
74.91
57.79
84.55
89.09
82.94
78.66
83.61
75.40
16.97
19.12
17.04
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
18,598
20,384
21,817
22,544
22,466
23,225
26,617
29,747
32,285
38,864
49,427
Fixed Assets
5,377
6,563
6,931
6,968
7,191
6,850
8,206
8,122
9,219
10,426
18,226
Current Assets
11,877
11,794
9,684
10,498
11,110
12,599
14,550
17,782
20,426
24,805
25,018
Capital Work in Progress
529
772
3,325
3,471
2,934
1,535
1,565
1,293
1,030
1,419
2,466
Investments
2,102
3,833
2,110
2,298
2,587
2,678
2,212
2,616
4,986
4,931
4,051
Other Assets
10,590
9,216
9,452
9,808
9,754
12,162
14,634
17,716
17,050
22,088
24,684
Total Liabilities
18,598
20,384
21,817
22,544
22,466
23,225
26,617
29,747
32,285
38,864
49,427
Current Liabilities
6,821
6,347
8,420
6,894
5,897
7,214
8,104
9,766
8,572
9,588
13,034
Non Current Liabilities
1,923
1,467
1,135
3,079
2,545
412
871
769
427
1,021
2,465
Total Equity
9,853
12,570
12,262
12,572
14,024
15,599
17,642
19,212
23,286
28,255
33,927
Reserve & Surplus
9,768
12,485
12,179
12,489
13,994
15,616
17,755
19,289
23,330
28,171
33,466
Share Capital
85
85
83
83
83
83
83
83
83
83
83
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-280
-47
-114
-124
-31
-27
1,286
3
-907
133
749
Investing Activities
-2,370
-1,610
-1,890
-1,483
-769
-495
-2,255
-2,565
-4,109
-4,034
-5,785
Operating Activities
2,524
3,263
2,144
1,803
2,870
2,984
3,570
2,811
5,888
4,543
4,643
Financing Activities
-433
-1,700
-369
-444
-2,133
-2,516
-30
-242
-2,686
-376
1,891
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
26.74 %
26.73 %
26.72 %
26.72 %
26.72 %
26.71 %
26.71 %
26.70 %
26.70 %
26.69 %
26.66 %
26.65 %
26.65 %
26.65 %
26.64 %
26.64 %
26.64 %
26.64 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
42.21 %
0.00 %
44.49 %
42.27 %
41.75 %
40.08 %
37.29 %
36.36 %
DIIs
14.25 %
15.08 %
20.92 %
21.95 %
24.46 %
24.95 %
24.47 %
23.38 %
23.05 %
21.99 %
21.04 %
16.21 %
18.31 %
20.73 %
21.48 %
22.90 %
25.62 %
26.74 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
8.31 %
7.76 %
8.14 %
8.27 %
8.37 %
8.22 %
8.06 %
7.84 %
7.59 %
7.51 %
7.91 %
8.44 %
8.25 %
8.07 %
8.07 %
8.07 %
8.20 %
8.04 %
Others
50.70 %
50.43 %
44.22 %
43.07 %
40.45 %
40.12 %
40.76 %
42.08 %
42.66 %
43.80 %
2.18 %
48.69 %
2.30 %
2.29 %
2.06 %
2.30 %
2.25 %
2.22 %
No of Share Holders
2,21,107
2,23,309
2,55,720
2,42,376
2,63,803
2,55,300
2,59,271
2,46,788
2,32,715
2,46,769
2,43,445
2,57,794
2,55,500
2,67,694
3,10,403
4,03,669
4,59,605
4,51,929

Dividend History

Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 20 20 20 20 25 25 30 40 40 8
Dividend Yield (%) 3.8 4.81 3.6 3.2 2.77 2.91 3.24 3.25 3.5 0.65

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
24 Oct 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 24 Oct 2025 1,321.70 1,234.50
13 Jul 2021 DIVIDEND Dividend
₹ 25.00 /share
 09 Jul 2021 1,060.40 1,097.91
13 Jul 2022 DIVIDEND Dividend
₹ 30.00 /share
 11 Jul 2022 781.62 896.74
12 Jul 2023 DIVIDEND Dividend
₹ 40.00 /share
 11 Jul 2023 986.65 1,033.17
17 Jul 2024 DIVIDEND Dividend
₹ 40.00 /share
 16 Jul 2024 1,258.69 1,329.21
29 Jul 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
 29 Jul 2024 1,258.69 1,378.43
27 Jul 2024 SPLIT Split
1:5
 28 Oct 2024 1,378.43 1,378.43
05 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 05 Nov 2024 1,310.23 1,268.30
23 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 23 Jan 2025 1,343.65 1,296.25
09 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 09 May 2025 1,187.20 1,148.00
10 Jul 2025 DIVIDEND Dividend
₹ 8.00 /share
 10 Jul 2025 1,148.00 1,269.40
23 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 23 Jul 2025 1,325.45 1,240.40
24 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
 24 Jul 2025 1,148.00 1,247.40

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication2 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 22, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 22, 2025
Closure of Trading WindowSep 22, 2025
Board Meeting Intimation for Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ending On September 30 2025Sep 22, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 19, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Sep 19, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Sep 18, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 16, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSSep 15, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 13, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Sep 10, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 06, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 05, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements)Regulations 2015Sep 04, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 02, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 01, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 29, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 Aug 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 20, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 20, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 20, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 13, 2025
Announcement Under Regulation 30 Of SEBI LODR Regulations 2015 - UpdatesAug 08, 2025
Announcement Under Regulation 30 - UpdatesAug 08, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 30, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 29, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionJul 25, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJul 24, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateJul 24, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 24, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMJul 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 23, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 23, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJul 23, 2025
Unaudited Financial Results For The Quarter Ended June 30 2025Jul 23, 2025
Board Meeting Outcome for Outcome Of Board MeetingJul 23, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Jul 22, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 22, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Jul 21, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 Jul 18, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 15, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 02, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 02, 2025
Business Responsibility and Sustainability Reporting (BRSR)Jun 30, 2025
Reg. 34 (1) Annual Report.Jun 30, 2025
Notice Convening The 41St Annual General MeetingJun 30, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
ICICI Prudential Value Direct-Growth
0.00%
-9322942
-2.19%
-2.20%
Nippon India Large Cap Fund Direct-Growth
0.00%
-5357429
-1.50%
-1.44%
ICICI Prudential Balanced Advantage Direct-Growth
0.00%
-4886509
-0.94%
-0.96%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
0.00%
-4633059
-9.47%
-8.85%
Nippon India Pharma Fund Direct-Growth
0.00%
-3916074
-5.90%
-5.69%
ICICI Prudential Large Cap Fund Direct-Growth
0.00%
-3655647
-0.64%
-0.65%
Mirae Asset Large & Midcap Fund Direct-Growth
0.00%
-3644961
-1.15%
-1.08%
ICICI Prudential Multi Asset Fund Direct-Growth
0.00%
-2909812
-0.57%
-0.59%
Mirae Asset ELSS Tax Saver Fund Direct-Growth
0.00%
-2814120
-1.39%
-1.35%
ICICI Prudential India Opportunities Fund Direct - Growth
0.00%
-2159488
-0.91%
-0.92%
Quant ELSS Tax Saver Fund Direct-Growth
0.00%
-2080408
-2.30%
-2.27%
Mirae Asset Large Cap Fund Direct- Growth
0.00%
-2077707
-0.66%
-0.66%
Nippon India Focused Fund Direct-Growth
0.00%
-1936811
-2.90%
-2.86%
Tata Value Fund Direct-Growth
0.00%
-1778619
-2.68%
-2.62%
ICICI Prudential Equity Savings Fund Direct-Growth
0.00%
-1102469
-0.88%
-0.83%
ICICI Prudential Equity & Debt Fund Direct-Growth
0.00%
-1041267
-0.29%
-0.20%
Sundaram Large Cap Fund Direct - Growth
0.00%
-1019304
-3.89%
-3.82%
Bandhan Value Fund Direct-Growth
0.00%
-1000000
-1.28%
-1.27%
HDFC Balanced Advantage Fund Direct-Growth
0.00%
-1000000
-0.12%
-0.12%
Mirae Asset Healthcare Fund Direct - Growth
0.00%
-946480
-4.27%
-4.13%
ICICI Prudential Large & Mid Cap Fund Direct Plan-Growth
0.00%
-936948
-0.50%
-0.51%
ICICI Prudential Nifty 50 Index Direct Plan-Growth
0.00%
-766740
-0.69%
-0.69%
PGIM India Midcap Fund Direct-Growth
0.00%
-750000
-0.83%
-0.83%
ICICI Prudential Innovation Fund Direct - Growth
0.00%
-661451
-1.17%
-0.95%
Tata Ethical Direct Plan-Growth
0.00%
-590000
-2.06%
-2.10%

Technical Indicators

RSI(14)
Neutral
39.35
ATR(14)
Less Volatile
23.28
STOCH(9,6)
Neutral
24.36
STOCH RSI(14)
Neutral
24.85
MACD(12,26)
Bearish
-6.45
ADX(14)
Weak Trend
19.39
UO(9)
Bearish
39.14
ROC(12)
Downtrend And Accelerating
-6.60
WillR(14)
Oversold
-84.45
Bearish
4
Neutral
5
Bullish
0
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Intraday Screeners
Candlestick Screeners
Technical Screeners
Fundamental Screeners
Price & Volume Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2025 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104